About

Graduated with a degree in BA Journalism from the University of South Wales (Cardiff) in 2021. Shortly afterwards, I fell into content writing for a couple of different companies writing about different subjects including science, tech, crypto, lifestyle etc. But journalism is where my heart truly lies, and just before I landed my role here, I did a journalism internship with an online publication called TheSocialTalks, where I finally had an opportunity to get my journalistic work published. The rest is history and, having always been interested in biology and medical science, I’m now living my dream as a junior reporter here at Labiotech. Outside of work, hobbies include reading, TV & Film, cooking, travelling, eating out, and a decent amount of wine tasting…

Articles by Willow Shah-Neville

A gene editing milestone: The FDA approves CASGEVY, the first CRISPR-based therapy

Five companies shaping Texas’ growing biotech hubs

In Depth 22 Nov 2023

Apellis’ Syfovre vs Astellas’ Izervay: the battle for a geographic atrophy treatment

Beyond insulin: six cutting-edge diabetes biotech companies you should know about

In Depth 16 Nov 2023

Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again

10 biotech companies leading innovation in the Asia-Pacific region

ADVERTISEMENT
Weekly Roundup 10 Nov 2023

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

In Depth 8 Nov 2023

Promising cure for COPD: is a breakthrough treatment within reach?

In Depth 6 Nov 2023

The biggest private biotech investments in October 2023

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

In Depth 30 Oct 2023

The ongoing search for an HIV cure: can CRISPR crack the code?

In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

ADVERTISEMENT